✦ LIBER ✦

Novel l-Xylose Derivatives as Selective Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitors for the Treatment of Type 2 Diabetes

✍ Scribed by Goodwin, Nicole C.; Mabon, Ross; Harrison, Bryce A.; Shadoan, Melanie K.; Almstead, Zheng Y.; Xie, Yiling; Healy, Jason; Buhring, Lindsey M.; DaCosta, Christopher M.; Bardenhagen, Jennifer

Book ID: 115443424
Publisher: American Chemical Society
Year: 2009
Tongue: English
Weight: 762 KB
Volume: 52
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm900951n

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5a-Carba-β-d-glucopyranose derivatives a

5a-Carba-β-d-glucopyranose derivatives as novel sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes

✍ Yoshihito Ohtake; Tsutomu Sato; Hiroharu Matsuoka; Masahiro Nishimoto; Naoki Tak 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 658 KB

Discovery of Dapagliflozin: A Potent, Se

Discovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes

✍ Meng, Wei; Ellsworth, Bruce A.; Nirschl, Alexandra A.; McCann, Peggy J.; Patel, 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 203 KB

C-Aryl 5a-carba-β-d-glucopyranosides as

C-Aryl 5a-carba-β-d-glucopyranosides as novel sodium glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes

✍ Yoshihito Ohtake; Tsutomu Sato; Hiroharu Matsuoka; Takamitsu Kobayashi; Masahiro 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 625 KB

Dapagliflozin: A Novel Sodium-Glucose Co

Dapagliflozin: A Novel Sodium-Glucose Cotransporter Type 2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus

✍ Niren K. Shah; Wasim E. Deeb; Rushab Choksi; Benjamin J. Epstein 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Dapagliflozin: A Once-Daily Oral Therapy

Dapagliflozin: A Once-Daily Oral Therapy Sodium-Glucose Cotransporter-2 Inhibitor for the Treatment of Adult Patients with Type 2 Diabetes

✍ Idris, ; Khalid Jadoon, 📂 Article 📅 2011 🏛 Libertas Academica 🌐 English ⚖ 631 KB

Remogliflozin etabonate, a selective inh

Remogliflozin etabonate, a selective inhibitor of the sodium-dependent transporter 2 reduces serum glucose in type 2 diabetes mellitus patients

✍ R. L. Dobbins; R. O’Connor-Semmes; A. Kapur; C. Kapitza; G. Golor; I. Mikoshiba; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 612 KB